Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients

Case definition for progressive multifocal leukoencephalopathy following treatment with monoclonal antibodies

(2012) Dirk Mentzer et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort

(2012) A. K. Trampe et al.   NEUROLOGY

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

(2012) Gary Bloomgren et al.   NEW ENGLAND JOURNAL OF MEDICINE

Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS

(2011) A. Vennegoor et al.   NEUROLOGY

Immune reconstitution inflammatory syndrome in natalizumab-associated PML

(2011) I. L. Tan et al.   NEUROLOGY

Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy

(2011) P. Vermersch et al.   NEUROLOGY

Successful Management of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy and Immune Reconstitution Syndrome in a Patient With Multiple Sclerosis

(2010) Alexandra Schröder et al.   ARCHIVES OF NEUROLOGY

Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis

(2010) Chen S Tan et al.   LANCET NEUROLOGY

Identification and Characterization of Mefloquine Efficacy against JC Virus In Vitro

(2009) M. Brickelmaier et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab

(2009) Werner Wenning et al.   NEW ENGLAND JOURNAL OF MEDICINE

Incidence, Clinical Presentation, and Outcome of Progressive Multifocal Leukoencephalopathy in HIV-Infected Patients during the Highly Active Antiretroviral Therapy Era: A Nationwide Cohort Study

(2008) Frederik Neess Engsig et al.   JOURNAL OF INFECTIOUS DISEASES